| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Marie D Burdick | |
| Robert M Strieter | |||
| John A Belperio | |||
| Michael P Keane | |||
| Steven M Dubinett | |||
| Sherven Sharma | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 351-360 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer | |
| P478 | volume | 1028 |
| Q50058176 | A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates |
| Q33316250 | A complex pattern of chemokine receptor expression is seen in osteosarcoma |
| Q39561132 | A novel orthotopic mouse model of head and neck cancer with molecular imaging. |
| Q34882979 | Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? |
| Q54578226 | Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis. |
| Q38747771 | Atypical chemokine receptors in cancer: friends or foes? |
| Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
| Q54266909 | CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer. |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q37816561 | Chemokines in cancer related inflammation |
| Q36780595 | Chemokines in the biology of lung cancer. |
| Q37400654 | Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis |
| Q28473512 | Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties |
| Q42292642 | Elevated level of some chemokines in plasma of gastric cancer patients. |
| Q35008957 | Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients |
| Q26852248 | Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis |
| Q28743229 | Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer |
| Q84443727 | Expression of stromal derived factor-1 (SDF-1) and chemokine receptor (CXCR4) in bone metastasis of renal carcinoma |
| Q33500845 | Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes |
| Q39860590 | Gonadotropin-releasing hormone-regulated chemokine expression in human placentation |
| Q36372747 | In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines |
| Q30276128 | Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases |
| Q36603426 | Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment |
| Q34063800 | Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer |
| Q34593085 | New functions of aminoacyl-tRNA synthetases beyond translation |
| Q36402780 | PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation |
| Q36233709 | Pathogenesis of lung cancer: 100 year report |
| Q42568212 | Potential combinatorial effects of recombinant atypical chemokine receptors in breast cancer cell invasion: A research perspective |
| Q34134446 | Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis |
| Q58862468 | Role of Tumor-Associated Macrophages (TAM) in Cancer Related Inflammation |
| Q37082574 | Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. |
| Q36120825 | Role of chemokines in tumor growth |
| Q34754045 | Tailoring tyrosine kinase inhibitors to fit the lung cancer genome. |
| Q36150219 | Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment |
| Q51072169 | The Inflammatory CXC Chemokines, GROαhigh, IP-10low, and MIGlow, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression. |
| Q35768528 | The genetic control of avascular area in mouse oxygen-induced retinopathy |
| Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
| Q38079588 | The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas |
Search more.